Comparative Pharmacology
Head-to-head clinical analysis: DEXASPORIN versus OTICAIR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXASPORIN versus OTICAIR.
DEXASPORIN vs OTICAIR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dexasporin is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It binds to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of pro-inflammatory mediators such as prostaglandins and leukotrienes.
Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication; fluocinolone acetonide is a corticosteroid that induces phospholipase A2 inhibitory proteins, reducing prostaglandin and leukotriene synthesis, thereby suppressing inflammation.
1 to 2 mg/kg intramuscular or intravenous every 8 hours.
1-2 sprays into each affected ear twice daily for 7 days. Topical route.
None Documented
None Documented
3-4 hours (prolonged to 10-15 hours in renal impairment; monitor CrCl <30 mL/min)
4.2 hours; prolonged in renal impairment (up to 12 hours in creatinine clearance <30 mL/min)
Renal excretion (80-90% unchanged), biliary/fecal (10-20%)
Renal: 85% unchanged; biliary/fecal: 10%
Category C
Category C
Corticosteroid/Antibiotic Combination
Otic Antibiotic/Corticosteroid